Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Lung Cancer

Lung Cancer Research Reagents

Lung cancer remains the leading cause of cancer-related mortality worldwide, with NSCLC accounting for ~85% of all cases. abinScience provides a comprehensive portfolio of antibodies, recombinant proteins, and ELISA kits covering EGFR, ALK, KRAS, PD-L1, VEGF, and other key oncogenic drivers and immune checkpoints critical to lung cancer research and drug development. RUO

Key Biomarkers & Targets

EGFR
ErbB1 / HER1
Mutated in ~15–30% of NSCLC; primary target for TKIs (gefitinib, osimertinib). 150+ antibodies and biosimilar-grade proteins available.
Antibodies • Proteins • Biosimilars
ALK
Anaplastic Lymphoma Kinase
ALK rearrangements drive ~5% of NSCLC. Reagents for fusion protein detection and crizotinib/alectinib mechanism studies. 110+ products.
Antibodies • Biosimilars
PD-L1 / PD-1
CD274 / CD279
Central to immune checkpoint blockade in NSCLC. PD-L1 expression (IHC TPS) guides first-line pembrolizumab eligibility. 260+ reagents across both targets.
Antibodies • Proteins • Biosimilars
KRAS
K-Ras4B
KRAS G12C mutation present in ~13% of NSCLC — the first "undruggable" oncogene to yield approved therapies (sotorasib, adagrasib).
Antibodies
VEGF / VEGFR
Vascular Endothelial Growth Factor
Key angiogenesis axis; bevacizumab backbone of NSCLC combination regimens. 160+ antibodies and recombinant proteins.
Antibodies • Proteins • Biosimilars
CEA
CEACAM5 / CD66e
Serum biomarker for adenocarcinoma subtype monitoring. Also emerging bispecific antibody target (cibisatamab). 80+ products.
Antibodies • Biosimilars

Why Researchers Choose abinScience for Lung Cancer

Driver Mutation Coverage Reagents targeting all major NSCLC actionable mutations — EGFR, ALK, ROS1, RET, NTRK, BRAF, MET, KRAS G12C — for comprehensive molecular profiling.
Checkpoint Immunotherapy Panel PD-1, PD-L1, CTLA-4, TIGIT, LAG-3, TIM-3 — supporting companion diagnostic development and immune response characterization.
Biosimilar-Grade Reference Proteins Research-grade biosimilars of approved NSCLC therapeutics for binding assays, cell-based potency tests, and pharmacokinetic studies.
Protein–Antibody–Kit Workflow Same target available as recombinant protein, detection antibody, and ELISA kit — streamline your assay development with one supplier.
Original Manufacturer Pricing Direct-from-manufacturer pricing with no distributor markup. Bulk and custom conjugation options available.

Common Research Applications

  1. Molecular subtyping: EGFR/ALK/ROS1/KRAS mutation status drives NSCLC treatment selection. Use our antibodies (IHC, WB) and proteins (ELISA, SPR) for genotype-phenotype validation.
  2. PD-L1 expression profiling: Quantify PD-L1 on tumor cells and tumor-infiltrating immune cells to stratify immunotherapy response potential.
  3. Anti-angiogenic drug development: VEGF/VEGFR proteins and antibodies for receptor-binding assays, endothelial tube formation studies, and bevacizumab biosimilar comparability.
  4. Liquid biopsy biomarker validation: CEA antibodies (ELISA/IHC validated) for circulating biomarker research in NSCLC monitoring.

Documents & QC Data

Download product datasheets, validation images (WB/IHC/IF/FC), CoA, and application protocols on each product page. All data is lot-specific.

FAQs

Which EGFR antibodies detect both wild-type and mutant forms?

We offer anti-EGFR polyclonal antibodies (ELISA, IHC, WB; Human/Mouse/Rat) and monoclonal clones (e.g., 1A112–1A114, IHC/WB validated). Research-grade EGFR biosimilar proteins are also available.

Do you offer ALK fusion-specific reagents?

We offer anti-ALK polyclonal antibodies with ELISA, IHC, and WB validation, monoclonal clones (e.g., SAA0129 with FC; ab324 with FC in FITC/APC/PE/PerCP), and research-grade ALK biosimilar proteins.

What PD-L1 scoring systems do your antibodies support?

Yes — we carry multiple anti-PD-L1 clones: 22C3 and SP142/SP263 (ELISA, IHC, WB; available in FITC/APC/PE/PerCP conjugates), plus clones 1A058–1A064 (ELISA, IHC, WB; unconjugated). Research use only, not companion diagnostics.

Can I get NSCLC-relevant multiplex panels?

We carry IHC-validated antibodies for EGFR, PD-L1 (22C3, SP142), and Ki-67. For targets like TTF-1 and CK7, see product pages for current application data. Contact us for panel assembly guidance.

Do you offer custom antibody development for novel lung cancer targets?

Yes — our parent company AtaGenix provides full custom antibody services from immunogen design through hybridoma production, covering novel NSCLC targets not yet in our catalog.

742 product results for "Lung Cancer"

Options+
Options
Confirm
  • Product types
    0 selected
    Stable Cell Lines (4)
    Assay Kit (1)
    Proteins (96)
    Research Biosimiliar (7)
    Biosimilars (2)
    Research Biosimilar (288)
    Antibodies (344)
  • Expression system
    0 selected
    Mammalian Cells (319)
    Insect Cells (2)
    HEK293T (4)
    E. coli (54)
  • Target
    0 selected
    MET/HGFR & EGFR/ERBB1 (2)
    LAG-3 & PD-1 (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    CD274/PD-L1 & TGFBR2 (1)
    CD47/MER6 & CD274/PD-L1 (2)
    CD340/ERBB2/HER2 (6)
    CD274/PD-L1 & CD134/OX40 (1)
    B7-H3 & EGFR (1)
    CD152/CTLA4 & CD274/PD-L1 (1)
    VEGFA & CD279/PD-1 (1)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    PDL1 & VEGF (1)
    RPL17 (1)
    ENPP7 (1)
    GOLGA5 (1)
    TRIM33 (3)
    KEAP1 (5)
    KRAS (2)
    TP53/p53 (16)
    KRT7 (4)
    CD292/BMPR1A (7)
    CD279/PDCD1/PD1 & TIGIT (1)
    CD246/ALK (9)
    TNIP2 (1)
    CD332/FGFR2 (18)
    CD279/PD-1 & IL2 (1)
    CD172a/SIRPA & CD340/ERBB2 (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    CD28 & EGFR (1)
    CD334/FGFR4 (12)
    CD274/PD-L1 & SLT-Ia (1)
    LAG3 & PD-1 (1)
    CD340/ERBB2 & CD279/PD-1 (1)
    PD-L1 & TGF-Beta (1)
    RET/c-RET (6)
    RRM2B (1)
    TGFBR1 (1)
    CD333/FGFR3 (13)
    CD223/LAG3 & CD279/PD-1 (4)
    EGFR/ERBB1 & CD16a/FCGR3A (1)
    4-1BB & HER2 (1)
    CD340/ERBB2 & CD3 (1)
    EGFR/ERBB1 & CD28 (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    ERBB2 / HER2 / CD340 & CD137/4-1BB/TNFRSF9 (1)
    CD274/PD-L1 & CD28 (1)
    EGFR/ERBB1/HER1 (5)
    EGFRvIII & CD3E (1)
    CD152/CTLA4 & CD279/PD-1 (1)
    CD73/NT5E (1)
    Methyltransferase/Met (1)
    TP53BP1 (2)
    HER2 (domain III) (1)
    MET/HGFR (32)
    GFRA2 (1)
    TP53TG5 (1)
    Met (3)
    PDL1 (6)
    EGFR/ERBB1 & TGFBR2/TGFR-2 (1)
    NKX2-1 (1)
    CD19 & PD-L1 & CD3E & CD137 (1)
    Fluorescein & CD274/PD-L1 (1)
    CLEC14A (2)
    CD279/PD-1 & CD274/PD-L1 (1)
    Met e 1/Tropomyosin (2)
    MeT-y Methyltransferase (1)
    SLITRK6 (6)
    ACVR1B (1)
    CD273/PD-L2/PDCD1LG2 (13)
    EGFR/ERBB1 (69)
    VSIR/VISTA & CD274/PD-L1 (1)
    CTLA4 & PD1 (2)
    CD274/PD-L1 & CD279/PD-1 (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    ACVRL1/ALK-1 & VEGFA (1)
    CD331/FGFR1 & KLB/Beta-klotho (1)
    KRAS/K-Ras 2 (G12D) (1)
    TRIM27 (1)
    TRIM13 (1)
    EGFR/ERBB1/HER1&c-MET (1)
    PD-L1 & VEGF (1)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    BRAF/B-Raf (5)
    FGFRL1 (1)
    GFRA1 (1)
    ACVRL1/ALK-1 (18)
    TP53 (1)
    EGFR/ERBB1 & c-Met/HGFR (1)
    MSRA (1)
    PD1 / VEGF-A (2)
    CD340/ERBB2/HER2 & CD3E (1)
    WRAP53 (1)
    ERBIN (2)
    EML4-ALK (1)
    CD331/FGFR1 (7)
    EGFR & CD3E (1)
    EGFR/ERBB1 & ERBB3/HER3 (1)
    CD340/ERBB2/HER2&CD314/KLRK1/NKG2D (1)
    KRAS/K-Ras 2 (G12C) (1)
    CD279/PD-1 & CD47/MER6 (1)
    CD274/PD-L1 & VEGFA (1)
    CD47 & PD-1 (1)
    TRIAP1 (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    FRS2 (1)
    CD274/PD-L1 & CD152/CTLA4 (1)
    ROS1 (4)
    KRAS/K-Ras 2 (7)
    EGFR/ERBB1/HER1 & CD3E & Albumin/HSA (1)
    ACVR1C (1)
    ACVR1/ALK-2 (6)
    CD279/PDCD1/PD1 (6)
    NRG1/Neuregulin-1 (5)
    TIGIT & CD274/PD-L1 (1)
    EGFR (2)
    EGFRvIII-specific/EGFR variant III (2)
    EGFR/ERBB1 & CD3E (2)
    TIGAR (1)
    CD278/ICOS & CD279/PD-1 (1)
    CD274/PD-L1/B7-H1 (5)
    CD274/PD-L1 & CD3E (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    4-1BB & FAP (1)
    CD274/PD-L1 (81)
    CD340/ERBB2 & ERBB3/HER3 (1)
    MET/c-Met/HGFR (1)
    GZMM (1)
    PD-L1 / VEGF-A (1)
    EGFR/ERBB1/HER1 & CD3E (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    CD360/IL21R & CD279/PD-1 (1)
    p-TP53 (1)
    CD137/4-1BB & CD340/ERBB2 (2)
    CD366/TIM-3 & CD279/PD-1 (2)
    PIK3CA (2)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    TIGIT & CD279/PD-1 (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    CD274/PD-L1 & CD47/MER6 (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    SLITRK5 (1)
    CD340/ERBB2 (90)
    p53 (R175H mutation) pHLA Complex (1)
    CD314/KLRK1/NKG2D & EGFR/ERBB1/HER1 (1)
    EGFRvIII (1)
    CD279/PD-1 (106)
    EGFR/ERBB1 & LGR5 (1)
    CD340/ERBB2 & CD3E (5)
  • Species
    0 selected
    Rat (1)
    Dog (8)
    Tupaia chinensis (5)
    Cynomolgus monkey (1)
    Felis catus (Cat) (4)
    Human (352)
    Homo sapiens (Human) (9)
    Chinese mitten crab (1)
    Greasyback shrimp (1)
    Mouse (36)
    Mus musculus (Mouse) (3)
    Cat (3)
  • Applications
    0 selected
    IHC-F (3)
    SPR (1)
    IF (20)
    FACS (14)
    ELISA (585)
    Neutralization (12)
    Functional assay (14)
    IHC (92)
    FuncS (21)
    WB (220)
    Bioactivity: FACS (285)
    in vivo blockade (2)
    Functional assay (288)
    Blocking (3)
    in vivo (3)
    in vivo blocking of PD-1/PD-L signaling (2)
    SDS-PAGE (96)
    Research in vivo (288)
    Depletion (1)
    FCM (184)
    Research in vivo (3)
    IP (4)
    in vivo PD-L1 blockade (3)
    Immunogen (96)
    in vitro PD-L1 blockade (3)
    Bioactivity testing in progress (75)
    RIA (2)
  • Reactivity
    0 selected
    Cynomolgus (1)
    B7-H1 / PD-L1 / CD274 (1)
    Macaca mulatta (1)
    Kryptolebias marmoratus (1)
    Cavia porcellus (1)
    Pongo abelii (4)
    Drosophila sechellia (1)
    CD279/PDCD1/PD1 (1)
    Drosophila simulans (1)
    Marmota monax (1)
    Mouse (87)
    Dog (5)
    Limanda limanda (1)
    Bos taurus (4)
    Cyprinus carpio (1)
    Rasheed rat sarcoma virus (1)
    Cat (2)
    Drosophila virilis (1)
    Oryctolagus cuniculus (1)
    Rat (30)
    Meleagris gallopavo (1)
    Pan troglodytes (1)
    Danio rerio (3)
    Pig (3)
    Drosophila willistoni (1)
    human hepatitis E virus genotype 2a (1)
    Tupaia belangeri (1)
    Mesocricetus auratus (1)
    Pleurodeles waltl (1)
    Drosophila ananassae (1)
    Mus musculus (Mouse) (1)
    Chinese mitten crab (2)
    Xenopus laevis (4)
    Greasyback shrimp (1)
    Homo sapiens (Human) (6)
    Hepatitis E virus (HEV) (1)
    Drosophila yakuba (1)
    Human (249)
    Moloney murine sarcoma virus (1)
    Drosophila erecta (1)
    Chlorocebus aethiops (1)
    Equus asinus (1)
    Avian retrovirus IC10 (1)
    Chicken (4)
    Monodelphis domestica (1)
    Drosophila grimshawi (1)
    Homo sapiens (2)
    Macaca fascicularis (2)
    Avian rous-associated virus type 1 (1)
    Harvey murine sarcoma virus (1)
    Artemia salina (1)
    Murine sarcoma virus NS.C58 (1)
    Drosophila mauritiana (1)
    Tupaia chinensis (2)
    Macaca fuscata fuscata (1)
    Coturnix japonica (1)
    Kirsten murine sarcoma virus (1)
    Carassius auratus (1)
    Oryzias latipes (1)
    Drosophila melanogaster (1)
  • Host species
    0 selected
    Alpaca (8)
    Caninized (1)
    Chimeric (13)
    Dog (5)
    HEK293T (4)
    Rabbit (79)
    Rat (23)
    Humanized (69)
    Human (281)
    Mouse (148)
  • Clonality
    0 selected
    Polyclonal (66)
    Monoclonal (570)
  • Conjugate
    0 selected
    Unconjugated (443)
    FITC (34)
    APC (34)
    PerCP (34)
    PE (34)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only